Apoptotic Death of Prostate Cancer Cells by a Gonadotropin-Releasing Hormone-II Antagonist

Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2

(2013) Hsien-Ming Wu et al.   BMC CANCER

Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines

(2013) Ludmila Sviridonov et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Correlated Evolution of Gonadotropin-Releasing Hormone and Gonadotropin-Inhibitory Hormone and Their Receptors in Mammals

(2012) Basant K. Tiwary   NEUROENDOCRINOLOGY

Autophagy in Idiopathic Pulmonary Fibrosis

(2012) Avignat S. Patel et al.   PLoS One

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Autophagy in immunity and inflammation

(2011) Beth Levine et al.   NATURE

Self-Renewing Pten-/-TP53-/- Protospheres Produce Metastatic Adenocarcinoma Cell Lines with Multipotent Progenitor Activity

(2011) Wassim Abou-Kheir et al.   PLoS One

Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis

(2010) Lena F. Burbulla et al.   HUMAN MOLECULAR GENETICS

A Gonadotropin-Releasing Hormone-II Antagonist Induces Autophagy of Prostate Cancer Cells

(2009) D.-K. Kim et al.   CANCER RESEARCH

International epidemiology of prostate cancer: Geographical distribution and secular trends

(2008) Peter D. Baade et al.   MOLECULAR NUTRITION & FOOD RESEARCH